Show
Sort by
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
- Journal Article
- A1
- open access
TARP as antigen in cancer immunotherapy
-
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
-
- Journal Article
- A1
- open access
Deciphering myeloid-derived suppressor cells : isolation and markers in humans, mice and non-human primates
-
Evaluation of a xenogeneic vascular endothelial growth factor-2 vaccine in two preclinical metastatic tumor models in mice
-
The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression
-
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
-
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
-
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
-
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma